World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
10597
World Ranking
3806
National Ranking
37

T. Mark Doherty publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where T. Mark Doherty sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 118 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

T. Mark Doherty D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where T. Mark Doherty sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

T. Mark Doherty is affiliated with the Statens Serum Institut in Denmark. Their research spans several areas in medicine with a focus on infectious diseases, gastrointestinal disorders, and dermatological conditions.

The scientist has contributed to multiple fields of study, predominantly in Medicine and Immunology and Microbiology. Their more specialized subfields include Parasitology, Epidemiology, Gastroenterology, Surgery, and Dermatology.

Key topics explored by Doherty in their publications cover:

  • Herpesvirus Infections and Treatments
  • Vector-borne infectious diseases
  • Gastrointestinal Tumor Research and Treatment
  • Gastrointestinal disorders and treatments
  • Acne and Rosacea Treatments and Effects
  • Bartonella species infections research
  • Platelet Disorders and Treatments

Recent notable papers authored or co-authored by Doherty include:

  • Healthy ageing: Herpes zoster infection and the role of zoster vaccination, 2023, npj Vaccines
  • A Systematic Review with a Demonstrative Case of KIT and DOG-1 Expressing Gastrointestinal Stromal Tumors Harboring ETV6-NTRK3 Fusions, 2025, Clinical Cancer Research
  • Healthy ageing: Herpes zoster infection and the role of the adjuvanted recombinant zoster vaccine, 2022, European Journal of Public Health
  • 1938 Prevention of herpes zoster infection with a recombinant zoster vaccine to support healthy ageing in older adults, 2024, Age and Ageing
  • Analysis of 3144 case reports in the gastrointestinal stromal tumor literature: Identification of underappreciated demographics, clinical presentations, and biology, 2024, Surgical Oncology Insight

Doherty regularly collaborates with several researchers, frequently co-authoring with Nicolas Lecrenier, Thomas Breuer, Mark Antkowiak, Jason K. Sicklick, and Desmond Curran.

Their work is published in a range of scientific journals, including:

  • npj Vaccines
  • Clinical Cancer Research
  • European Journal of Public Health
  • Age and Ageing
  • Surgical Oncology Insight

In addition to journal articles, Doherty has contributed to the field through book publications. Notably, they authored Computer Aided Text-Reconstruction and Transcription CATT-Manual published as an eBook by Mohr Siebeck eBooks in 2025.

Best Publications

  • The success and failure of BCG - implications for a novel tuberculosis vaccine.

    Peter Andersen;T. Mark Doherty

  • Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

    Robert S Wallis;Madhukar Pai;Madhukar Pai;Dick Menzies;Dick Menzies;T Mark Doherty

  • Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients.

    T. Mark Doherty;Abebech Demissie;Joseph Olobo;Dawit Wolday

  • Exchanging ESAT6 with TB10.4 in an Ag85B Fusion Molecule-Based Tuberculosis Subunit Vaccine: Efficient Protection and ESAT6-Based Sensitive Monitoring of Vaccine Efficacy

    Jes Dietrich;Claus Aagaard;Robert Leah;Anja W. Olsen

  • Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.

    Jan A.M. Langermans;T. Mark Doherty;Richard A.W. Vervenne;Tridia van der Laan

  • Biomarkers for tuberculosis disease activity, cure, and relapse

    Robert S. Wallis;T. Mark Doherty;Phillip Onyebujoh;Mahnaz Vahedi

  • Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

    Jaap T. van Dissel;Sandra M. Arend;Corine Prins;Peter Bang

  • Comparison of different standards for real-time PCR-based absolute quantification.

    S Dhanasekaran;T Mark Doherty;John Kenneth

  • Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with Mycobacterium tuberculosis

    Abebech Demissie;Eliane M. S. Leyten;Markos Abebe;Liya Wassie

  • Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity.

    Jes Dietrich;Claire Andersen;Rino Rappuoli;T. Mark Doherty

  • The prognosis of latent tuberculosis: can disease be predicted?

    Peter Andersen;T. Mark Doherty;Madhukar Pai;Karin Weldingh

  • Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2

    Abebech Demissie;Markos Abebe;Abraham Aseffa;Graham Rook

  • Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression

    Nathalia A. Giese;Lucia Gabriele;T. Mark Doherty;Dennis M. Klinman

  • Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis

    Ann Williams;Graham J. Hatch;Simon O. Clark;Karen E. Gooch

  • Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis

    Aurelie Cobat;Aurelie Cobat;Caroline J. Gallant;Leah Simkin;Gillian F. Black

  • Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.

    Jaap T. van Dissel;Darius Soonawala;Simone A. Joosten;Corine Prins

  • Heparin-Binding-Hemagglutinin-Induced IFN-γ Release as a Diagnostic Tool for Latent Tuberculosis

    Jean-Michel Hougardy;Kinda Schepers;Sammy Place;Annie Drowart

  • Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens.

    Karin Weldingh;Ida Rosenkrands;Limei Meng Okkels;T. Mark Doherty

  • Vaccines for Tuberculosis: Novel Concepts and Recent Progress

    T. Mark Doherty;Peter Andersen

  • Maternal immunization: where are we now and how to move forward?

    Ivo Vojtek;Ilse Dieussaert;T Mark Doherty;Valentine Franck

  • Oral Vaccination with Subunit Vaccines Protects Animals against Aerosol Infection with Mycobacterium tuberculosis

    T. Mark Doherty;Anja Weinrich Olsen;Laurens van Pinxteren;Peter Andersen

Frequent Co-Authors

Peter E. Andersen
Peter E. Andersen Technical University of Denmark
Alimuddin Zumla
Alimuddin Zumla University College London
Abraham Aseffa
Abraham Aseffa Armauer Hansen Research Institute
Tom H. M. Ottenhoff
Tom H. M. Ottenhoff Leiden University Medical Center
Graham A. W. Rook
Graham A. W. Rook University College London
Laurent Abel
Laurent Abel Université Paris Cité
Aurélie Cobat
Aurélie Cobat Grenoble Alpes University
Camille Locht
Camille Locht Institut Pasteur
Robert S. Wallis
Robert S. Wallis Aurum Institute
Giuseppe Del Giudice
Giuseppe Del Giudice GlaxoSmithKline (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research career paths. Many professionals interested in clinical roles pursue nursing programs tailored for immunology or related fields. For example, if you are a non-nurse aiming to enter nursing, exploring online BSN programs for non nurses can provide a strong foundation.

Accelerated options are also available for those who hold degrees in other healthcare disciplines. The accelerated NP programs help speed up the route to becoming a Nurse Practitioner (NP), a popular career for those combining clinical expertise with immunology knowledge.

For Nurse Practitioners looking to deepen their critical care skills, obtaining an acute care nurse practitioner certification is a common next step. This certification is especially relevant in immunology-related acute care settings.

Salary prospects vary widely by location and specialization. Understanding the DNP salary by state can help guide your career decisions based on earning potential.

Best Scientists Citing T. Mark Doherty

Trending Scientists

Recently Published Articles